Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Fedratinib combined with ropeginterferon alfa-2b in patients with myelofibrosis (FEDORA): study protocol for a multicentre, open-label, Bayesian phase II trial
McIlroy, G., Gaskell, C., Jackson, A., Yafai, E., Tasker, R., Thomas, C., Fox, S., Boucher, R., Ghebretinsea, F., Harrison, C., Mead, A. J., McMullin, M. F. & Lax, S. (Contributor), Dec 2025, In: BMC Cancer. 25, 11 p., 56.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
Final results of ANICCA-Class II, a single arm, open-label phase II trial assessing nivolumab in tissue-specific class II expressing metastatic microsatellite stable colorectal cancer, with a parallel assessment of the immunoscore-immune checkpoint as a predictive biomarker for single-agent anti-PD-1
Middleton, G., Gaskell, C., Savage, J., Bridgewater, J., Ross, P., Saunders, M., Palmer, D., Plummer, R., Clive, S., Coyle, V., Thomas, A., Cunningham, D., Taniere, P. & Billingham, L., 17 Dec 2025, In: Journal for ImmunoTherapy of Cancer. 13, 12, 13 p., e012749.Research output: Contribution to journal › Article › peer-review
Open AccessFile4 Downloads (Pure) -
Multicentre adaptive randomised trial of GvHD prophylaxis following unrelated donor stem cell transplantation comparing Thymoglobulin versus calcineurin inhibitor-based or sirolimus-based post-transplant cyclophosphamide (Methods of T cell Depletion, MoTD trial)
Chakraverty, R., Kempshall, E., Dignan, F., Bloor, A., Collin, M., Raj, K., Davies, J., Potter, V., Malladi, R., Smith, S., Gates, S., Gaskell, C., Bishop, R., Hodgkinson, A. & Smith, G., 28 Jan 2025, In: BMJ open. 15, 1, 9 p., e086223.Research output: Contribution to journal › Article › peer-review
Open AccessFile59 Downloads (Pure) -
Selumetinib in Combination with Anti Retroviral Therapy in HIV-associated Kaposi sarcoma (SCART): an open-label, multicentre, phase I/II trial
Young, R. J., Kirkham, A., Savage, J., Gaskell, C., Johnson, S., Dockrell, D. H., Bower, M., Westwell, S., Bowman, C., Leahy, M., Woll, P. & Billingham, L., 19 Mar 2025, In: BMC Cancer. 25, 1, 505.Research output: Contribution to journal › Article › peer-review
Open AccessFile26 Downloads (Pure) -
Investigator choice of standard therapy versus sequential novel therapy arms in the treatment of relapsed follicular lymphoma (REFRACT): study protocol for a multi-centre, open-label, randomised, phase II platform trial
McIlroy, G., Lax, S., Gaskell, C., Jackson, A., Rhodes, M., Seale, T., Fox, S., Hopkins, L., Okosun, J., Barrington, S. F., Ringshausen, I., Ramsay, A. G., Calaminici, M., Linton, K. & Bishton, M., 25 Mar 2024, In: BMC Cancer. 24, 1, 13 p., 370.Research output: Contribution to journal › Article › peer-review
Open AccessFile55 Downloads (Pure)
Projects
- 2 Active
-
Beacon-2 Recordati
Pirrie, S. (Researcher), Gates, S. (Researcher), Gaskell, C. (Researcher) & Burke, A. (Principal Investigator)
1/06/25 → 31/05/34
Project: Industry
-
REFRACT (CR-UK): A Sequential Randomised Phase II Trial in Relapsed Follicular comparing standard Chemotherapy with Novel agents
Jackson, A. (Principal Investigator), Fox, S. (Co-Investigator), Gaskell, C. (Co-Investigator) & McIlroy, G. (Co-Investigator)
Genmab A/S, Cancer Research UK
1/02/22 → 31/07/32
Project: Research